3 results match your criteria: "Emory Addiction Center[Affiliation]"
Objective: Early identification of substance use during adolescence is imperative to reduce the risk of morbidity and mortality. The aim of this study was to determine the utility of the Global Appraisal of Individual Needs-Quick Version 4 (GAIN-Q4) at diagnosing substance use disorders (SUDs) in adolescents.
Methods: The GAIN-Q4 was developed from the GAIN-Quick Version 3 by adding items from the original measure (GAIN-I) to diagnose SUDs and provide level of care recommendations.
Development and Evaluation of the Global Appraisal of Individual Needs Quick Version 4 (GAIN-Q4) for ASAM Dimension Ratings and Placement Recommendations for Adolescents and Adults.
J Addict Med
December 2024
From the GAIN Coordinating Center, Lighthouse Institute, Chestnut Health Systems, Normal, IL (MLD, KCM, BDE); and Emory Addiction Center, Atlanta, GA (SIS, JWW).
Objectives: This article describes the development and evaluation of the Global Appraisal of Individual Needs Quick Version 4 (GAIN-Q4) for the American Society of Addiction Medicine (ASAM) 4th edition patient placement dimension ratings and level of care placement recommendations. The research questions are as follows: (1) Can the GAIN-Q4 replicate recommendations from the prior longer instrument within adolescents and adults? (2) What are the substantive differences in the results by age?
Methods: The 35- to 45-minute GAIN-Q4 was developed through modification of the GAIN-Q3 and evaluated in terms of its ability to predict ASAM dimensional ratings and level of care placement recommendations from the 60- to 120-minute GAIN-I instrument. Data were obtained from participants who are adolescents aged 12 to 17 years (n = 101,897) and adults 18 years and older (n = 204,711) interviewed between 2002 and 2018 across 530 US sites.
Qualitative Assessment of Barriers to Buprenorphine Access: The Role of Pharmacies.
Subst Use Misuse
October 2024
Emory Addiction Center, Atlanta, Georgia, USA.
Background: Patients continue to face challenges accessing medication for opioid use disorder (MOUD) despite attempts to loosen prescribing restrictions and streamline service provision. Past research has mainly focused on potential barriers surrounding prescribing practices for buprenorphine, but has had limited investigation into the role of pharmacies.
Objective: This study investigates the role of both pharmacists and pharmacies in creating or circumventing barriers to accessing buprenorphine for individuals in Georgia seeking medication for opioid use disorder (MOUD).